Printer Friendly
The Free Library
19,607,059 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Corporate Profile for EndoSonics Corporation, dated July 23, 1999.


--(BUSINESS WIRE)--

The following Corporate Profile is available for inclusion in your files. News releases for this client are distributed by Business Wire and also become part of the leading databases and online services, including all of the leading Internet-based services. -0-

Published Date:   July 23, 1999

Company Name:     EndoSonics Corporation

Address:          2870 Kilgore Road
                  Rancho Cordova, CA 95670

Main Telephone
 Number:          916/638-8008

Internet Home
 Page Address
  (URL)           www.EndoSonics.com

Chief Executive
 Officer:         Reinhard J. Warnking

Chief Financial
 Officer:         Richard L. Fischer

Investor Relations
 Contact:         Morgen Walke; Rep. John Swenson
 Business number: 415/296-7383

Public Relations
 Contact:         Morgen Walke; Rep. John Swenson
 Business number: 415/296-7383

Industry:         Medical Diagnostic Equipment

Trading Symbol/
 Exchange:        ESON/Nasdaq


Company description:

EndoSonics Corporation ("EndoSonics" or the "Company") develops, manufactures and markets intravascular ultrasound ("IVUS IVUS Intravascular ultrasound, see there ") imaging systems and percutaneous transluminal coronary angioplasty percutaneous transluminal coronary angioplasty
n. Abbr. PTCA
A procedure for enlarging a narrowed arterial lumen by peripheral introduction of a balloon-tip catheter followed by dilation of the lumen as the inflated catheter tip is
 ("balloon angioplasty balloon angioplasty: see under angioplasty. ") catheters to assist in the diagnosis and treatment of cardiovascular and peripheral vascular disease Peripheral Vascular Disease Definition

Peripheral vascular disease is a narrowing of blood vessels that restricts blood flow. It mostly occurs in the legs, but is sometimes seen in the arms.
. The Company's IVUS imaging products enhance the effectiveness of the diagnosis and treatment of coronary artery and other vascular diseases by providing important diagnostic information not available from conventional x-ray angiography angiography
 or arteriography

X-ray examination of arteries and veins with a contrast medium to differentiate them from surrounding organs. The contrast medium is introduced through a catheter to show the blood vessels and the structures they supply, including
.

In 1993, the Company commenced the Pinnacle Development Project to further enhance the image quality of its IVUS imaging products. This project resulted in the Five-64 catheter line and an enhancement to the Company's Oracle Imaging System.

Cardiometrics, Inc., ("Cardiometrics"), acquired by the Company in 1997, develops, manufactures and markets intravascular intravascular /in·tra·vas·cu·lar/ (in?trah-vas´ku-lar) within a vessel.

in·tra·vas·cu·lar
adj.
Within one or more blood vessels.
 medical devices to measure blood flow impairment caused by coronary artery disease coronary artery disease, condition that results when the coronary arteries are narrowed or occluded, most commonly by atherosclerotic deposits of fibrous and fatty tissue. . Cardiometrics' principal products, the FloWire(R)Doppler guide wire and FloMap(R) ultrasound instrument, represent an advance in functional testing of blood flow impairment, enabling cardiologists to evaluate the appropriateness of angioplasty interventions and assess post-procedural results directly in the cardiac catheterization laboratory.
COPYRIGHT 1999 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1999, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Jul 23, 1999
Words:292
Previous Article:Webvan Group, Inc. Raises an Additional $275 Million in Financing.
Next Article:Corporate Profile for Midcoast Energy Resources Inc, dated July 23, 1999.
Topics:



Related Articles
EndoSonics Announces Stock Buyback.
EndoSonics Announces Voluntary Recall of 200 MegaSonics Imaging Catheters Sold in the United States.
EndoSonics Reports Record Revenue and Net Income.
EndoSonics Names Jeffrey L. Elder as Chief Financial Officer.
EndoSonics Receives FDA Marketing Clearance for Third Generation IVUS Catheter, Avanar; Advanced Image Quality and Ease of Use.
JOMED Agrees to Acquire U.S. Company EndoSonics Corporation.
JOMED N.V. Announces Consummation of Second Step Merger With EndoSonics Corporation.
Radiance Wins Litigation With JOMED-Endosonics.
Correction.
OMRON Healthcare Announces Dissolution of Affiliated Company.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles